Latest News
Blue Bird Corporation (BLBD) Q3 2026 Earnings Call Transcript
Blue Bird Corporation (BLBD) Q3 2026 Earnings Call Transcript
The Chemours Company (CC) Q2 2026 Earnings Call Transcript
The Chemours Company (CC) Q2 2026 Earnings Call Transcript
Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call Transcript
Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call Transcript
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
BrainsWay: Building A Capital-Light Interventional Psychiatry Ecosystem
BrainsWay is transitioning from a device manufacturer to a capital-light ecosystem provider for interventional psychiatry, leveraging recurring revenue and minority investments. BWAY reported Q1-2026
AbCellera Biologics Inc. (ABCL) Q2 2026 Earnings Call Transcript
AbCellera Biologics Inc. (ABCL) Q2 2026 Earnings Call Transcript
Dave Inc. (DAVE) Q2 2026 Earnings Call Transcript
Dave Inc. (DAVE) Q2 2026 Earnings Call Transcript
GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript
GRAIL, Inc. (GRAL) Q2 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
Tutor Perini Corporation (TPC) Q2 2026 Earnings Call Transcript
Tutor Perini Corporation (TPC) Q2 2026 Earnings Call Transcript
ServiceNow: Why The Latest Quarter Is An Opportunity To Buy
ServiceNow remains a Strong Buy, with compelling growth, robust financials, and misunderstood AI integration driving upside potential. I'm closely monitoring Now Assist's path to $1B ACV, backlog and
OraSure Technologies Q2 Earnings Call Highlights
OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth i
Pacific Biosciences of California Q2 Earnings Call Highlights
Pacific Biosciences of California NASDAQ: PACB reported second-quarter 2026 revenue of $39 million, roughly flat from $39.8 million a year earlier, while announcing an immediate leadership transition
Paysign Q2 Earnings Call Highlights
Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utiliz
McEwen Q2 Results: Net Income of $9.6M ($0.16 per Share), Compared with $3.0M ($0.06 per Share) in Q2 2025; Exploration Results Driving Resource Growth Across All Sites; New Stock Mine in Timmins Nearing Production, with Mine Life Extended
(See Glossary for Defined Terms) TORONTO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) today announced its second quarter financial results for the period
Amtech Systems, Inc. (ASYS) Q3 2026 Earnings Call Transcript
Amtech Systems, Inc. (ASYS) Q3 2026 Earnings Call Transcript
e.l.f. Beauty, Inc. (ELF) Q1 2027 Earnings Call Transcript
e.l.f. Beauty, Inc. (ELF) Q1 2027 Earnings Call Transcript
OUTFRONT Media Inc. (OUT) Q2 2026 Earnings Call Transcript
OUTFRONT Media Inc. (OUT) Q2 2026 Earnings Call Transcript
Figma, Inc. (FIG) Q2 2026 Earnings Call Transcript
Figma, Inc. (FIG) Q2 2026 Earnings Call Transcript
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call Transcript
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call Transcript